NFL Biosciences SA (ALNFL.PA)
EUR 1.35
(-1.17%)
EUR 1.35
(-1.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.97 Million EUR | 65.75% |
| 2022 | 2.39 Million EUR | -35.0% |
| 2021 | 3.68 Million EUR | 539.09% |
| 2020 | 576.63 Thousand EUR | 23.48% |
| 2019 | 466.99 Thousand EUR | 75.64% |
| 2018 | 265.88 Thousand EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5 Million EUR | 26.16% |
| 2023 Q4 | 3.97 Million EUR | -28.82% |
| 2023 FY | 3.97 Million EUR | 65.75% |
| 2023 Q2 | 5.57 Million EUR | 132.87% |
| 2022 FY | 2.39 Million EUR | -35.0% |
| 2022 Q4 | 2.39 Million EUR | -21.3% |
| 2022 Q2 | 3.04 Million EUR | 0.0% |
| 2021 FY | 3.68 Million EUR | 539.09% |
| 2021 Q2 | 1.42 Million EUR | 0.0% |
| 2020 FY | 576.63 Thousand EUR | 23.48% |
| 2019 FY | 466.99 Thousand EUR | 75.64% |
| 2018 FY | 265.88 Thousand EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ABIONYX Pharma SA | 14.71 Million EUR | 73.007% |
| ABIVAX Société Anonyme | 327.06 Million EUR | 98.786% |
| Adocia SA | 24.95 Million EUR | 84.089% |
| Aelis Farma SA | 26.28 Million EUR | 84.892% |
| Biophytis S.A. | 11.93 Million EUR | 66.734% |
| Advicenne S.A. | 12.4 Million EUR | 67.997% |
| genOway Société anonyme | 31.84 Million EUR | 87.53% |
| IntegraGen SA | 8 Million EUR | 50.369% |
| Medesis Pharma S.A. | 1.92 Million EUR | -106.123% |
| Neovacs S.A. | 47.53 Million EUR | 91.647% |
| Plant Advanced Technologies SA | 14.91 Million EUR | 73.375% |
| Quantum Genomics Société Anonyme | 3.74 Million EUR | -5.975% |
| Sensorion SA | 46.49 Million EUR | 91.46% |
| Theranexus Société Anonyme | 7.23 Million EUR | 45.14% |
| TME Pharma N.V. | 2.49 Million EUR | -59.399% |
| Valbiotis SA | 33.24 Million EUR | 88.058% |
| TheraVet SA | 7.53 Million EUR | 47.299% |
| Valerio Therapeutics Société anonyme | 35.27 Million EUR | 88.743% |
| DBV Technologies S.A. | 165.65 Million USD | 97.603% |
| Genfit S.A. | 173.87 Million EUR | 97.716% |
| GeNeuro SA | 6.31 Million EUR | 37.103% |
| Innate Pharma S.A. | 184.19 Million EUR | 97.844% |
| Inventiva S.A. | 69.13 Million EUR | 94.257% |
| MaaT Pharma SA | 42.93 Million EUR | 90.751% |
| MedinCell S.A. | 36.94 Million EUR | 89.253% |
| Nanobiotix S.A. | 93.89 Million EUR | 95.771% |
| OSE Immunotherapeutics SA | 81.9 Million EUR | 95.152% |
| Poxel S.A. | 4.82 Million EUR | 17.673% |
| GenSight Biologics S.A. | 9.08 Million EUR | 56.304% |
| Transgene SA | 45.21 Million EUR | 91.219% |
| Valneva SE | 469.39 Million EUR | 99.154% |